Acute administration of morphine stimulates the secretion of hypothalamic-pituitary-adrenal (HPA) hormones, ACTH, -endorphin and corticosterone in the rat. In this study we investigated the effects of repeated multiple-dose morphine on HPA activity under two different conditions: without or with water restriction stress. Rats received six intermittent injections of morphine (6·25 mg/kg per injection, s.c.) every 2 h and were killed 30 min after the last injection.
Introduction
Opiates are important in the control of the secretion of hypothalamic-pituitary-adrenal (HPA) stress hormones. In the rat, acute morphine administration, as a stressor, stimulates HPA activity, as reflected by elevated adrenocorticotropin (ACTH) and corticosterone levels in peripheral blood (e.g. Buckingham & Cooper 1984 , Ignar & Kuhn 1990 . In sharp contrast, in man, both acute and chronic morphine administration inhibits the HPA axis (Kreek 1973 , 1978 , Cushman & Kreek 1974 . In studies of isolated rat hypothalami, opioid agonists acting through mu opioid receptors stimulate corticotropin-releasing factor (CRF) secretion (Buckingham & Cooper 1986) . In contrast, opioid agonists have inhibitory effects on neurotransmitter-stimulated CRF release from the hypothalamus in vitro (Buckingham 1985 , Tsagaraki et al. 1989 . The findings indicate that the effects of morphine on CRF secretion may depend on the presence of other stimuli.
It has been established that environmental stress modulates the effects of drugs of abuse on the acquisition of drug self-administration behavior, locomotor activity, and reinstatement of drug self-administration after extinction (Shaham et al. 1996 , Piazza & Le Moal 1997 , Kreek & Koob 1998 . For example, glucocorticoid treatment and stress have been reported to augment the reinforcing and locomotor-activating properties of opiates, cocaine and amphetamine (e.g. Kalivas & Stewart 1991 , Piazza et al. 1991 . To investigate the molecular effects of morphine, Borsook et al. (1994) have used a transgenic mouse model with a human preproenkephalin--galactosidase fusion gene to study the modulation of stress-regulated preproenkephalin gene expression in the hypothalamus by morphine. They found that acute morphine administration prior to a hypertonic saline stress produces superinduction of both preproenkephalin mRNA expression and neuronal activity in the hypothalamus, which do not show a response to either morphine or hypertonic saline stress as an independent stimulus. The findings suggest that the effects of morphine on endogenous opioid activity may also depend on the presence of stress.
It is not known whether or not the modulating effects of acute morphine on the HPA activity or proopiomelanocortin (POMC) mRNA expression are affected by stress. Therefore, the present study was undertaken to determine the effects of acute intermittent multiple-dose morphine in modulating the response of the HPA activity, and on POMC mRNA expression under two different conditions: without or with water restriction stress.
Materials and Methods

Animal maintenance
Male Wistar rats (190-220 g; Charles River Laboratories, Kingston, NY, USA) were housed individually in a stress-minimized facility with free access to water and food. Animals were adapted to a standard 12 h light:12 h darkness cycle (lights on from 0900 h to 2100 h) for 7 days. Before drug administration, all animals were handled and received s.c. injections of saline for 6 days in order to minimize injection-induced stress. Animals were randomly assigned to treatment groups. On day 7, animals received s.c. injections of morphine (6 6·25 mg/kg) or an equal volume of physiological saline (6 1 ml/kg) every 2 h during the light cycle at 1030 h, 1230 h, 1430, 1630, 1830 and 2030 h under two conditions: without or with water restriction. Access to water was removed 30 min before the first injection of the experimental day. Of note, according to a published report (Aguilera et al. 1993) , approximately 12% of water intake is during the light cycle. The experiment consisted of four groups: (1) saline or (2) morphine with free access to water, and (3) saline or (4) morphine with water restriction. Animals were killed 30 min after the last injection (2100 h).
Preparation of RNA extracts
Brains were rapidly removed, and the hypothalamus, anterior lobe and neurointermediate lobe/posterior lobe of the pituitary were dissected on ice, homogenized in guanidinium thiocyanate buffer and extracted with acidic phenol and chloroform as previously described (Chomczynski & Sacchi 1987) .
Solution hybridization RNase protection-trichloroacetic acid (TCA) precipitation assays
The solution hybridization RNase protection-TCA precipitation protocol has been described in detail in earlier reports from our laboratory (Branch et al. 1992 , Spangler et al. 1993 . Assays for POMC or CRF mRNA have recently been described in detail (Zhou et al. 1996a,b) . A 760 base pair fragment from the rat CRF cDNA (a kind gift from Dr R C Thompson at the University of Michigan) or a 538 base pair fragment from the rat POMC cDNA (a kind gift from Dr J L Roberts at The Mount Sinai Medical Center in New York) was cloned into the polylinker region of the pSP64 plasmid (Promega, Madison, WI, USA) in both the sense and antisense orientations. The plasmid pS/E (a pSP65 derivative; a kind gift from Drs T Nilsen and P Maroney at Case Western University) was used to synthesize riboprobe for the 18S rRNA for determination of total RNA. 33 P-Labeled cRNA antisense probes and unlabeled RNA sense standards were synthesized using an SP6 transcription system. A denaturing agarose gel was used to ensure that a single full-length transcript had been synthesized from each plasmid.
RNA extracts were dried in 1·5 ml Eppendorf tubes and resuspended in 30 µl containing 150 000 to 300 000 c.p.m. of a probe in 2 TESS (10 mM N-Tris(hydroxy-methyl)methyl-2-aminoethane sulfonic acid, pH 7·4; 10 mM EDTA; 0·3 M NaCl; 0·5% SDS). Samples were covered with mineral oil and hybridized overnight at 75 C. For RNase treatment, 250 µl of a buffer containing 0·3 M NaCl; 5 mM EDTA; 10 mM Tris-HCl, pH 7·5; 40 µg/ml RNase A (Worthington, Freehold, NJ, USA) and 2 µg/ml RNase T1 (Calbiochem, San Diego, CA, USA) were added and each sample was incubated at 30 C for 30-60 min. TCA precipitation was effected by the addition of 1 ml of a solution containing 5% TCA and 0·75% sodium pyrophosphate. One drop of 0·5% bovine serum albumin was added to co-precipitate the RNA. Precipitates were collected onto a filter in sets of 24 using a cell harvester (Brandel, Gaithersburg, MD, USA) and measured in a scintillation counter with liquid scintillant (Beckman, Fullerton, CA, USA).
The procedure to measure mRNA levels involved comparison of values obtained from experimental samples (brain or pituitary extracts) with those obtained for a set of calibration standards. The calibration standards had known amounts of an in vitro sense transcript whose concentration was determined by optical absorbance at 260 nm. Each standard also contained 10 µg yeast total RNA or E. coli tRNA so that the calibration standards would be subject to non-specific background signals similar to the experimental extracts. The set of calibration standards included those with no added sense transcript and those containing between 1·25 and 80 pg of the sense transcript. The optimal hybridization conditions were: 50% formamide at 75 C for POMC; no formamide at 75 C for CRF. A new standard curve was generated each time experimental samples were analyzed and all extracts of a particular tissue were assayed for each mRNA as a group on a single day. Total cellular RNA concentrations were measured by hybridization of diluted extracts to a 33 P-labeled probe complementary to 18S rRNA at 75 C. The calibration standards contained 10 µg E. coli tRNA plus either 0·0 or from 2·5 to 40 ng of total rat brain RNA whose concentration was determined by optical absorbance at 260 nm.
Radioimmunoassays
At the time of decapitation of each rat, trunk blood was collected in EDTA tubes placed on ice, spun in a refrigerated centrifuge, and plasma was separated and stored at 80 C. Corticosterone levels were assayed using a rat corticosterone kit from ICN Biomedicals (Costa Mesa, CA, USA). ACTH immunoreactivity levels were assayed from unextracted plasma using a kit from Nichols Institute (San Juan Capistrano, CA, USA). All ACTH or corticosterone values were determined in duplicate in a single assay, and intra-assay coefficients of variation for ACTH and corticosterone were 4·1% and 1·5% respectively.
Data analysis
Data in graphs are presented as the means ... To evaluate the statistical significance of differences between treatment groups, a two-way analysis of variance (ANOVA) was conducted for each tissue (drug treatment with two levels: saline, morphine; water condition with two levels: water, water restriction), followed by Newman-Keuls post hoc tests. The accepted level of significance was P<0·05. Since earlier studies reported an effect of morphine on hypothalamic POMC mRNA levels without water restriction (Bronstein et al. 1990 , Wardlaw et al. 1996 , a Student's t-test was carried out between the saline-and morphine-treated groups without water restriction.
Results
Effects of acute intermittent morphine without or with water restriction on plasma ACTH and corticosterone levels
For plasma ACTH (Fig. 1A) , two-way ANOVA showed a significant drug treatment water condition interaction (F (1,38) =19·24, P<0·0001). Acute intermittent morphine administration led to significant elevations of plasma ACTH levels without water restriction (Newman-Keuls post hoc test, P<0·05). Water restriction without morphine also significantly increased plasma ACTH levels (P<0·05). However, there was no increase when morphine was administered under the water restriction condition.
For plasma corticosterone ( Fig. 1B) , two-way ANOVA also showed a significant drug treatment water con-dition interaction (F (1,41) =13·51, P<0·001). Acute intermittent morphine administration without water restriction caused significant elevations of plasma corticosterone levels (P<0·005). Water restriction did not significantly increase plasma corticosterone levels. There was no increase when morphine was administered under the water restriction condition, similar to the changes in plasma ACTH levels as shown in Fig. 1A .
Effects of acute intermittent morphine without or with water restriction on CRF mRNA levels in the hypothalamus
For CRF mRNA in the hypothalamus (Fig. 2) , two-way ANOVA showed a significant drug treatment water condition interaction (F (1, 20) =5·27, P<0·05). However, Newman-Keuls post hoc tests showed no significant differences in CRF mRNA levels in the hypothalamus among the pair-wise comparisons of the groups. 
Effects of acute intermittent morphine without or with water restriction on POMC mRNA levels in the pituitary
For POMC mRNA in the anterior pituitary, two-way ANOVA showed a significant main effect for drug treatment (morphine vs saline, F (1,44) =5·33, P<0·05), a significant main effect for water condition (water vs water restriction, F (1,44) =14·11, P<0·001), and a significant drug treatment water condition interaction (F (1,44) = 7·33, P<0·01). Without water restriction, acute intermittent morphine administration did not change POMC mRNA levels in the anterior pituitary (Fig. 3A) . Water restriction without morphine significantly increased POMC mRNA in the anterior pituitary (P<0·0005). However, there was no increase when the animals were treated with morphine under the water restriction condition.
As shown in Fig. 3B , POMC mRNA levels in the neurointermediate lobe/posterior lobe of the pituitary were not altered after acute intermittent morphine administration, water restriction or their combination. Figure 4 shows POMC mRNA levels in the same hypothalamic extracts as shown in Fig. 2 for CRF mRNA. Two-way ANOVA just failed to show a significant drug treatment water condition interaction (F (1,31) =3·48, P=0·07). Without water restriction the mean levels of POMC mRNA were approximately 65% higher after acute intermittent morphine administration than the mean saline control levels. Since earlier studies had shown an effect of morphine on hypothalamic POMC mRNA levels without water restriction (Bronstein et al. 1990 , Wardlaw et al. 1996 , a similar comparison was made between the morphine-treated group and the saline control with-out water restriction. A Student's t-test showed that acute intermittent morphine administration significantly increased POMC mRNA levels in the hypothalamus (t=2·49, P<0·05). Water restriction had no effect on the POMC mRNA levels, and there was no increase in the hypothalamic POMC mRNA levels when morphine was administered under the water restriction condition.
Effects of acute intermittent morphine without or with water restriction on POMC mRNA levels in the hypothalamus
Discussion
In the present study we observed that after acute morphine injections in this intermittent pattern there was a significant elevation of both plasma ACTH and corticosterone levels. The results are consistent with and extend earlier findings of the stimulatory effects of single-dose morphine administration on HPA activity (Buckingham & Cooper 1984 , Nikolarakis et al. 1987 , 1989 , Ignar & Kuhn 1990 . The importance of CRF in the hypothalamus in modulating the stimulatory effects on the HPA axis has been shown in another drug of abuse, cocaine (Moldow & Fischman 1987 , Rivier & Vale 1987 , Rivier & Lee 1994 , Zhou et al. 1996b ). However, the results from studies on the regulation of the HPA axis by morphine are not clear. Unlike cocaine, the stimulatory effect of a single dose of morphine on ACTH release is only slightly reduced if rats are pretreated with a specific CRF antiserum (Nikolarakis et al. 1987) . Also, given at the lowest effective dose, morphine still stimulates release of ACTH in the presence of a specific CRF antiserum (Nikolarakis et al. 1989 ). These results suggest that the stimulatory effects of morphine probably involve ACTH-releasing substances other than CRF and, in fact, unlike cocaine, acute intermittent morphine administration in the present study did not lead to a significant increase in CRF mRNA levels in the hypothalamus.
Consistent with a previous report (Aguilera et al. 1993) , the present experiments showed that plasma ACTH levels were significantly elevated after 12-h water restriction stress, with a slight, but not significant elevation of plasma corticosterone levels. Under this particular stressor condition, we found that there was a significant increase in POMC mRNA levels in the anterior pituitary. It is well established and has been repeated recently (Zhou et al. 1996a ) that POMC mRNA expression in the anterior pituitary is subject to glucocorticoid negative feedback control. Therefore, the blunted corticosterone secretion, resulting in a reduction of the usual glucocorticoid inhibition during stress, may account for the significant increase in POMC mRNA levels in the anterior pituitary found in this study.
We also examined the effect of acute intermittent morphine on pituitary-adrenal function in the rat under the mild stress condition of water restriction. Interestingly, it was found that, when the animals received morphine and the water restriction stress as two combined stimuli, there was no increase in plasma ACTH levels. Concurrent with the blunted ACTH response, morphine also inhibited the stress-induced elevations of POMC mRNA in the anterior pituitary. Thus, morphine effectively blunts the classical HPA activity caused by this water restriction stressor. Although the mechanisms involved in these interactions between morphine and the water restriction stress are not clear, our results suggest that the inhibitory effects of morphine on stress-responsive enhanced ACTH secretion, at least in part, involve a POMC mechanism at the level of the anterior pituitary. Lamberts et al. (1983) showed a direct inhibition of ACTH release from the rat pituitary in vitro by the [Met 5 ]enkephalin derivative FK 33824 but not by -endorphin (which was not naloxone reversible). This explanation is also supported by a report from Rittmaster et al. (1985) , showing that morphine blunted the ACTH response to exogenous CRF in the human. Alternatively, the inhibition by morphine on stress-induced HPA activation may be mediated through pituitary-independent mechanisms. It has been shown that inhibitory modulation of HPA activity by opioids in rats appears to occur through direct inhibition of CRF release from the hypothalamus (Plotsky 1986). Taken together, these findings suggest that morphine may play a counter-regulatory role in modulating HPA stress responsivity.
In rats, acute (1 or 2 day) morphine administration results in increased ACTH or corticosterone secretion, while animals treated on a chronic basis with morphine (3 days or more) show attenuation of the morphine-induced ACTH or corticosterone response, with the development of tolerance after longer morphine administration (Buckingham & Cooper 1984 , Ignar & Kuhn 1990 . In man, in sharp contrast, both acute and chronic morphine administration reduce ACTH and cortisol levels, exhibiting an inhibitory effect on the HPA axis. For instance, basal levels of ACTH and cortisol are significantly disrupted in active heroin addicts: suppression of ACTH and cortisol and abnormal diurnal rhythms of these hormones are found (Kreek 1973 , 1978 , Cushman & Kreek 1974 . Animal studies have shown that exposure to stress potentiated morphine-induced analgesia (Calcagnetti & Holtzman 1992) , and prevented the development of tolerance to morphine analgesia (Vaccarino & Couret 1995) , suggesting that stress may enhance opioid receptormediated effects. However, we observed that water restriction stress did not lead to the potentiation of the HPA activation induced by acute intermittent morphine administration. In fact, there was an effectively blunted HPA response to this stress when morphine was administered. Regardless of the mechanisms responsible for the interactions between morphine and stress, our findings show that the stimulatory effects of morphine on the HPA axis are absent in the presence of water restriction stress. In the hypothalamus, our present finding of alterations of POMC mRNA levels by morphine in this acute intermittent multiple-dose regimen is different from previous reports, indicating that the effect of opioids on POMC expression appears to be complex, with different effects reported using different administration paradigms. For example, POMC mRNA in the hypothalamus tended to decrease after 7 days of morphine treatment by pellets, although significant alterations were noted in one of two experiments (Bronstein et al. 1990 ). Wardlaw et al. (1996) recently reported that morphine treatment by pellets for 10 days suppressed POMC mRNA levels in the hypothalamus of the castrated rat. POMC mRNA levels in the pituitary were not reported in either of these two studies (Bronstein et al. 1990 , Wardlaw et al. 1996 . Previous studies on the effects of opioid agonists on the brain and pituitary -endorphin content have reported that chronic treatment with opioid agonists did not change the immunoreactive -endorphin content in the hypothalamus, thalamus, midbrain, amygdala or pituitary of the rat (Ragavan et al. 1983 ).
In the present study, however, we found that repeated multiple-dose morphine administration in this intermittent pattern produced a significant increase in POMC mRNA levels in the hypothalamus, with no alterations in the pituitary. Relatively low levels of mu opioid receptors but relatively high levels of kappa opioid receptors are expressed in the hypothalamus of the rat (Thompson et al. 1993) . Thus, the effects of morphine on POMC mRNA levels may not be direct. A possible model to account for our findings is one in which the effects of morphine may be mediated through GABAergic inhibitory interneurons that express opiate receptors (van den Pol & Trombley 1993) . There are precedents for apparently excitatory effects of opiates being mediated by opiate inhibition of GABAergic interneurons in the ventral tegmental area (e.g. Di Chiara & Imperato 1988 , Johnson & North 1992 ), hippocampus (Cohen et al. 1992 ) and periaqueductal grey (Pan et al. 1990 ). In the present study, it was also found that acute intermittent morphine administration under the stress condition of water restriction did not cause an increase in POMC mRNA levels in the hypothalamus, despite a significant increase seen when the rats received morphine as an independent stimulus. The combination of morphine administration with a stressor appears to prevent the response to acute intermittent morphine, probably because the inhibitory GABAergic interneurons may escape exogenous opiate control.
In summary, in the present study we found that acute morphine, administered in an intermittent pattern, stimulated HPA activity. However, when the animals were under a water restriction stress condition, acute intermittent morphine failed to stimulate the HPA axis. The results suggest that the effects of morphine on HPA activity depend on the presence of stress. Our data further show that the increases in both POMC mRNA levels in the anterior pituitary and ACTH secretion in the blood, induced by a stress, are inhibited by acute intermittent morphine, probably indicating that opioids play a counterregulatory role on the stress response by inhibiting the stress-response cascade. In addition, the findings of the absence of any morphine effect on POMC mRNA levels in the hypothalamus under a stress condition indicate that the effects of morphine on brain opioid gene expression also depend on the presence of stress.
The importance of environmental stress to alter drugrelated behavior has been investigated recently. For example, animals' behavioral responsiveness to opiates, cocaine, and amphetamine can be altered by prior exposure to environmental stress (Kalivas & Stewart 1991 , Piazza et al. 1991 , Kreek & Koob 1998 . To our best knowledge, this study is the first demonstration, in an in vivo study, that morphine may play a counter-regulatory role on a stress response and opioid gene expression. 
